Gene: ARL6
Official Full Name: ARF like GTPase 6provided by HGNC
Gene Summary: The protein encoded by this gene belongs to the ARF-like (ADP ribosylation factor-like) sub-family of the ARF family of GTP-binding proteins which are involved in regulation of intracellular traffic. Mutations in this gene are associated with Bardet-Biedl syndrome (BBS). A vision-specific transcript, encoding long isoform BBS3L, has been described (PMID: 20333246). [provided by RefSeq, Apr 2016]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO25196 | ARL6 Knockout cell line (HeLa) | Human | ARL6 | 1:3~1:6 | Negative | Online Inquiry |
KO25197 | ARL6 Knockout cell line (HCT 116) | Human | ARL6 | 1:2~1:4 | Negative | Online Inquiry |
KO25198 | ARL6 Knockout cell line (HEK293) | Human | ARL6 | 1:3~1:6 | Negative | Online Inquiry |
KO25199 | ARL6 Knockout cell line (A549) | Human | ARL6 | 1:3~1:4 | Negative | Online Inquiry |
ARL6 Gene Knockout Cell Lines are genetically engineered cell lines designed to eliminate the expression of the ARL6 gene, a member of the ADP-ribosylation factor-like (ARL) family of proteins, which are critical in various cellular processes such as intracellular trafficking, cytoskeletal organization, and signal transduction. By disrupting the ARL6 gene, these cell lines provide researchers with a powerful tool for investigating the specific roles and regulatory functions of ARL6 in cellular mechanisms and disease states.
The key function of ARL6 revolves around its involvement in the transport processes within the cells, particularly in cilia formation and function. Dysfunction of ARL6 has been linked to several human diseases, including ciliopathies, which manifest through defects in the cilia, leading to tissue and organ dysfunction. These knockout cell lines allow for clearer dissection of the gene's role, enabling researchers to utilize various biochemical assays, imaging techniques, and cellular behavior studies to determine the contributions of ARL6 to both normal physiology and disease pathology.
In the research and clinical settings, ARL6 gene knockout cell lines are invaluable for elucidating disease mechanisms, screening for potential therapeutic interventions, and validating drug targets. They provide a direct model to examine the consequences of disrupted ARL6 function, facilitating advancements in both basic and translational science.
Unlike traditional cell lines, which may express ARL6 and mask its pathology, the ARL6 knockout lines uniquely offer a clean background devoid of the gene's activity, providing clearer and more specific insights. Furthermore, the ability to manipulate the genetic landscape of these cells enhances the versatility of experimental designs, making them suitable for a wide range of studies.
For researchers and clinicians invested in understanding the complexities of cellular signaling and disease mechanisms, ARL6 Gene Knockout Cell Lines represent a crucial resource. Our company specializes in providing high-quality, genetically validated biological products tailored to advancing research and therapeutic discovery. With an unwavering commitment to excellence and innovation, we empower scientists in their quest to uncover groundbreaking discoveries.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.